OPTITHERA confirms that the introduction of its multiPRS test is cost effective in the care of renal complications of patients with diabetes

March 1, 2021

Need more information about this research?

Contact us

Interested in learning more about the

Call us at 514 529-3374

or send us an email at

2815 Sherbrooke Street East, Suite 240
Montreal, Quebec, Canada  H2K 1H2

Alert me as soon as the Optithera test is available.

Abonnement - Anglais